HYTN Innovations Inc (TSE:HYTN) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
HYTN Innovations Inc., a pharmaceutical company known for producing psychoactive and psychotropic compounds, has achieved a significant milestone by obtaining an additional GMP certification that includes distribution for international markets. This expansion of its Kelowna manufacturing facility’s capabilities under its existing Drug Establishment Licence enables HYTN to distribute its non-sterile pharmaceutical products, such as cannabis medicines, directly to key markets globally.
For further insights into TSE:HYTN stock, check out TipRanks’ Stock Analysis page.